116 related articles for article (PubMed ID: 30051618)
1. Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31.
Chen N; Kroger CJ; Tisch RM; Bachelder EM; Ainslie KM
Adv Healthc Mater; 2018 Sep; 7(18):e1800341. PubMed ID: 30051618
[TBL] [Abstract][Full Text] [Related]
2. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
3. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.
Rabinovitch A; Suarez-Pinzon WL
Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885
[TBL] [Abstract][Full Text] [Related]
4. Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes.
Lu G; Rausell-Palamos F; Zhang J; Zheng Z; Zhang T; Valle S; Rosselot C; Berrouet C; Conde P; Spindler MP; Graham JG; Homann D; Garcia-Ocaña A
Diabetes; 2020 Aug; 69(8):1692-1707. PubMed ID: 32381645
[TBL] [Abstract][Full Text] [Related]
5. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
6. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
7. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
9. Foxp3-expressing CD4(+)T cells under the control of INF-gamma promoter prevent diabetes in NOD mice.
Wang R; Han G; Wang J; Song L; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Mol Ther; 2007 Aug; 15(8):1551-7. PubMed ID: 17534268
[TBL] [Abstract][Full Text] [Related]
10. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.
Li CR; Mueller EE; Bradley LM
Immunol Lett; 2015 Feb; 163(2):199-205. PubMed ID: 25447401
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
Jamison BL; Neef T; Goodspeed A; Bradley B; Baker RL; Miller SD; Haskins K
J Immunol; 2019 Jul; 203(1):48-57. PubMed ID: 31109955
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of type 1 diabetes.
Li L; Yi Z; Tisch R; Wang B
Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
Tomasoni R; Basso V; Pilipow K; Sitia G; Saccani S; Agresti A; Mietton F; Natoli G; Colombetti S; Mondino A
Eur J Immunol; 2011 Jul; 41(7):2086-96. PubMed ID: 21480212
[TBL] [Abstract][Full Text] [Related]
17. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection.
Johnson MM; Collier MA; Hoang KV; Pino EN; Graham-Gurysh EG; Gallovic MD; Zahid MSH; Chen N; Schlesinger L; Gunn JS; Bachelder EM; Ainslie KM
Mol Pharm; 2018 Nov; 15(11):5336-5348. PubMed ID: 30296381
[TBL] [Abstract][Full Text] [Related]
18. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
[TBL] [Abstract][Full Text] [Related]
20. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression.
Kauffman KJ; Kanthamneni N; Meenach SA; Pierson BC; Bachelder EM; Ainslie KM
Int J Pharm; 2012 Jan; 422(1-2):356-63. PubMed ID: 22037446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
